Alizyme has a late stage, diversified portfolio of competitive products for the treatment of obesity and type 2 diabetes, ulcerative colitis and mucositis.
19/11/08
Interim Management Statement
16/09/08
Takeda Milestone Payment
05/09/08
Update on Board Change
29/08/08
Interim Report 2008
09/04/08
Annual Report & Accounts 2007